Indexed metadata

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

S. Loibl, A. Schneeweiss, J. Huober, M. Braun, J. Rey, J.-U. Blohmer, J. Furlanetto, D.-M. Zahm, C. Hanusch, J. Thomalla, C. Jackisch, P. Staib, T. Link, K. Rhiem, C. Solbach, P.A. Fasching, V. Nekljudova, C. Denkert, M. Untch

Source record

Source: Crossref

Published: Nov 1, 2022

DOI: 10.1016/j.annonc.2022.07.1940

Open original source ↗

Evidence graph

No public relationships recorded yet.

Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.